COMPASS BIOMED (FORMERLY KNOWN AS ARTERIOCYTE)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2007–2018

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2018	—	3	1
2017	—	4	1
2016	—	5	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	5	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
G2G Consulting	—	48

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	43
SENATE	43
Defense, Dept of (DOD)	19
Army, Dept of (Other)	2
Food & Drug Administration (FDA)	2
Natl Institutes of Health (NIH)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	28
Defense	Defense	20
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	8
Health Issues	Health Issues	4

COMPASS BIOMED (FORMERLY KNOWN AS ARTERIOCYTE) — Lobbying Disclosure | Poliscope